Information needs of older patients newly diagnosed with cancer.

Background: Understanding what information patients want and need is an important step in optimizing care. Therefore, we set out to collect all available evidence about the information that is most important to older patients with a new cancer diagnosis and whether or not these information needs are sufficiently addressed.

Method: A systematic literature review of Embase and Medline.

Development of a self-reported version of the G8 screening tool.

Introduction: The G8 is a widely used frailty screening tool in patients with cancer that was designed to be completed by healthcare professionals. A patient-reported version would enable a broader application. Aim of this study was to develop a self-reported version of the G8 and to assess its agreement with the original G8.

A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer.

Aim: The aim of this systematic review is to summarise all available data on the use of the G8 screening tool in geriatric oncology, focusing on the diagnostic accuracy of the G8 to predict the presence of impairments on geriatric assessment (GA) and on its association with different clinical outcomes (survival, course of treatment and patient-centred outcomes).

Methods: A systematic search in MEDLINE and EMBASE for studies on the use of the G8 in older patients with cancer.

Results: The literature search identified 8987 reports, of which 54 publications from 46 studies were included (including 18 conference abstracts).

Chemotherapy in the oldest old: Choices and outcomes.

Treatment decision-making in older patients with cancer is difficult due to a paucity of data evaluating chemotherapy tolerability in this population. We investigated the feasibility of chemotherapy in the oldest old and performed a singl-centre retrospective analysis of patients aged ≥80 years initiating chemotherapy for one of five common solid malignancies or non-Hodgkin lymphoma between 2010 and 2016. Treatment plan and course were extracted from medical files.